MIFEPRISTONE

Generic: MIFEPRISTONE

Corcept Therapeutics IncorporatedManufacturer
ORALRoute
MIFEPRISTONEActive Substance
2012-02-17Original Approval

MIFEPRISTONE is FDA application NDA202107, sponsored by CORCEPT THERAP. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
HAEMORRHAGE
343 reports
2
ABORTION INCOMPLETE
335 reports
3
OFF LABEL USE
150 reports
4
NAUSEA
121 reports
5
PREGNANCY
118 reports
6
VOMITING
115 reports
7
ANAEMIA
105 reports
8
DIZZINESS
95 reports
9
MATERNAL EXPOSURE DURING PREGNANCY
95 reports
10
PAIN
95 reports